Med Minerva, LLC
About Med Minerva
MedMinerva is an emerging healthcare-focused company, officially registered as Med Minerva LLC in San Diego, California. Formed in late 2024, the organization is actively building its presence in the medical community and is already involved in supporting innovation-focused events, including EYENOVATE, a global ophthalmic innovation conference.
Positioned at the intersection of medical science, professional education, and healthcare innovation, MedMinerva is dedicated to connecting clinicians, researchers, and healthcare leaders through collaborative opportunities that accelerate progress across medical fields. By fostering knowledge exchange, supporting thought leadership, and building professional networks, the company lays the foundation for a more connected and empowered healthcare community.
MedMinerva’s mission is to serve as a catalyst for progress in medicine, providing the tools, resources, and connections that enable clinicians and innovators to advance patient care, drive scientific discovery, and make meaningful contributions to the field. Though still in its early stages, MedMinerva’s vision reflects a commitment to nurturing collaboration, encouraging professional growth, and amplifying the voices of those shaping the future of healthcare.
About Biosimilar or Not to Biosimilar
This accredited, on-demand educational program offers healthcare professionals an expert-led, case-based exploration of biosimilar and branded anti-VEGF therapies for wet AMD, diabetic macular edema (DME), and diabetic retinopathy (DR). Delivered in video format, the activity presents real-world clinical scenarios designed to enhance patient-centered decision-making and support practical application in daily practice.
Learners can access the program at their convenience for up to one year, completing pre- and post-activity assessments to measure knowledge gain and post-activity evaluations to claim credit. Throughout the activity, participants receive a structured framework for evaluating, initiating, monitoring, and adjusting anti-VEGF therapies using evidence-informed, patient-specific approaches.
What sets this activity apart is its focus on translating complex clinical evidence into actionable strategies, empowering clinicians to make confident, individualized treatment decisions. By combining case-based learning with practical guidance, the program helps healthcare professionals enhance both their understanding and their impact in patient care.
How Pinnacle Supported Med Minerva, LLC through joint providership
Learn at Pinnacle partnered with MedMinerva to provide seamless accreditation for their educational activity, ensuring it met all requirements for CE/CME credit. By leveraging Pinnacle’s expertise in compliance and joint providership, the team managed the full accreditation framework—reviewing content for bias, overseeing disclosures and conflicts of interest, handling commercial support standards, and preparing all necessary documentation for accrediting bodies.
Learn at Pinnacle also created the Activity Detail Page, facilitated post-activity evaluations, generated certificates, and reported outcomes to the appropriate accrediting organizations. This comprehensive support allowed MedMinerva to focus entirely on delivering high-quality, expert-led education while Pinnacle ensured every learner could claim credit with confidence.
Through this partnership model, Learn at Pinnacle streamlined a process that is often complex and resource-intensive, providing flexibility, speed, and compliance expertise that empowered MedMinerva to launch their accredited activity efficiently and effectively.
